Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The efficacy of a 5-day intensive intravenous regimen (IVR), used as treatment for severely active Crohn's disease in 49 patients, has been evaluated retrospectively. The value of such systemic therapy has not been reported before. Immediate remission was achieved in 38 (76%) patients with no significant difference between those with established disease and those seen for the first time. Patients with ileocolonic disease had the poorest response. There was no apparent change in the natural history of the Crohn's disease after IVR therapy. Nevertheless, this is a safe and effective method of achieving remission in most sick patients with severely active Crohn's disease.

Type

Journal article

Journal

J Clin Gastroenterol

Publication Date

04/1986

Volume

8

Pages

154 - 159

Keywords

Adolescent, Adult, Aged, Crohn Disease, Drug Therapy, Combination, Female, Humans, Hydrocortisone, Infusions, Parenteral, Male, Metronidazole, Middle Aged, Prednisolone, Recurrence, Retrospective Studies, Tetracycline, Time Factors